| An autoinflammatory disease with deficiency of the interleukin-1–receptor antagonist I Aksentijevich, SL Masters, PJ Ferguson, P Dancey, J Frenkel, ... New England Journal of Medicine 360 (23), 2426-2437, 2009 | 1047 | 2009 |
| A randomized, controlled trial of oral propranolol in infantile hemangioma C Léauté-Labrèze, P Hoeger, J Mazereeuw-Hautier, L Guibaud, ... New England Journal of Medicine 372 (8), 735-746, 2015 | 833 | 2015 |
| Consensus-derived practice standards plan for complicated Kaposiform hemangioendothelioma BA Drolet, CC Trenor, LR Brandão, YE Chiu, RH Chun, R Dasgupta, ... The Journal of pediatrics 163 (1), 285-291, 2013 | 276 | 2013 |
| A consensus approach to wound care in epidermolysis bullosa E Pope, I Lara-Corrales, J Mellerio, A Martinez, G Schultz, R Burrell, ... Journal of the American Academy of Dermatology 67 (5), 904-917, 2012 | 252 | 2012 |
| PHACE syndrome: consensus-derived diagnosis and care recommendations MC Garzon, LG Epstein, GL Heyer, PC Frommelt, DB Orbach, AL Baylis, ... The Journal of pediatrics 178, 24-33. e2, 2016 | 249 | 2016 |
| Timolol maleate 0.5% or 0.1% gel‐forming solution for infantile hemangiomas: a retrospective, multicenter, cohort study A Chakkittakandiyil, R Phillips, IJ Frieden, E Siegfried, I Lara‐Corrales, ... Pediatric dermatology 29 (1), 28-31, 2012 | 246 | 2012 |
| Topical timolol gel for infantile hemangiomas: a pilot study E Pope, A Chakkittakandiyil Archives of dermatology 146 (5), 564-565, 2010 | 226 | 2010 |
| Recurrence and outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children Y Finkelstein, GS Soon, P Acuna, M George, E Pope, S Ito, NH Shear, ... Pediatrics 128 (4), 723-728, 2011 | 216 | 2011 |
| Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma SC Li, KS Torok, E Pope, F Dedeoglu, S Hong, HT Jacobe, ... Arthritis care & research 64 (8), 1175-1185, 2012 | 193 | 2012 |
| The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measures T Arkachaisri, S Vilaiyuk, S Li, KM O’NEIL, E Pope, GC Higgins, M Punaro, ... The Journal of rheumatology 36 (12), 2819-2829, 2009 | 173 | 2009 |
| SJS/TEN 2017: building multidisciplinary networks to drive science and translation KD White, R Abe, M Ardern-Jones, T Beachkofsky, C Bouchard, ... The Journal of Allergy and Clinical Immunology: In Practice 6 (1), 38-69, 2018 | 170 | 2018 |
| Oral versus high-dose pulse corticosteroids for problematic infantile hemangiomas: a randomized, controlled trial E Pope, BR Krafchik, C Macarthur, D Stempak, D Stephens, M Weinstein, ... Pediatrics 119 (6), e1239-e1247, 2007 | 169 | 2007 |
| Topical imiquimod in the treatment of infantile hemangiomas: a retrospective study NTC Ho, P Lansang, E Pope Journal of the American Academy of Dermatology 56 (1), 63-68, 2007 | 155 | 2007 |
| Topical timolol maleate treatment of infantile hemangiomas K Püttgen, A Lucky, D Adams, E Pope, C McCuaig, J Powell, ... Pediatrics 138 (3), 2016 | 148 | 2016 |
| Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach–Merritt phenomenon YE Chiu, BA Drolet, F Blei, M Carcao, J Fangusaro, ME Kelly, A Krol, ... Pediatric blood & cancer 59 (5), 934-938, 2012 | 143 | 2012 |
| Rebound growth of infantile hemangiomas after propranolol therapy SD Shah, E Baselga, C McCuaig, E Pope, J Coulie, LM Boon, MC Garzon, ... Pediatrics 137 (4), 2016 | 130 | 2016 |
| Dermatological complications of continuous subcutaneous insulin infusion in children and adolescents LS Conwell, E Pope, AM Artiles, A Mohanta, A Daneman, D Daneman The Journal of pediatrics 152 (5), 622-628, 2008 | 127 | 2008 |
| Stroke in children with posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities (PHACE … DH Siegel, KA Tefft, T Kelly, C Johnson, D Metry, P Burrows, E Pope, ... Stroke 43 (6), 1672-1674, 2012 | 122 | 2012 |
| A double‐blind, randomized, placebo‐controlled trial of topical tacrolimus 0· 1% vs. clobetasol propionate 0· 05% in childhood vitiligo N Ho, E Pope, M Weinstein, S Greenberg, C Webster, BR Krafchik British Journal of Dermatology 165 (3), 626-632, 2011 | 113 | 2011 |
| High-potency steroid use in children with vitiligo: a retrospective study J Kwinter, J Pelletier, A Khambalia, E Pope Journal of the American Academy of Dermatology 56 (2), 236-241, 2007 | 112 | 2007 |
